After seeking care for escalating memory lapses, Diane Roussel received a devastating Alzheimer's diagnosis. She began ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

The experimental drug, NU-9, targets toxic proteins that may trigger Alzheimer’s decades before memory loss begins. In mice, ...

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

Activating two somatostatin receptors enhances amyloid beta breakdown and improves memory in models of Alzheimer’s disease. Scientists at Karolinska Institutet in Sweden and the RIKEN Center for Brain ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

Long considered irreversible, Alzheimer’s is being reexamined after a new animal study focused on the brain’s energy system.

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.

Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to justify their cost, the health spending watchdog has said. Donanemab and ...

With few treatments available to stop or reverse Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of walking back cognitive decline. Alzheimer’s cases are rising in the ...